Motus GI Holdings Inc MOTS

NAS: MOTS | ISIN: US62014P1084 3/05/2024

0,072 USD (-4,64%)

(-4,64%) 3/05/2024

Toon enkel gratis nieuws

9 november 2023 · Thinking about buying stock in Applied Therapeutics, Motus GI Holdings, Plug Power, Kinnate Biopharma, or Virgin Galactic Holdings? · Persbericht

31 oktober 2023 · Thinking about buying stock in Tempest Therapeutics, Applied Digital, Ford Motor, Lockheed Martin, or Motus GI Holdings? · Persbericht

16 maart 2021 · Motus GI Reports Fourth Quarter 2020 Financial Results and Provides Corporate Update · Persbericht

15 maart 2021 · Motus GI Announces First Patient Enrolled in a Pilot Study Using the Pure-Vu® System for Patients with Lower GI Bleeding Being Conducted by a Leading U.S. Medical Center · Persbericht

2 maart 2021 · Motus GI to Release Fourth Quarter and Full Year 2020 Results and Provide a Business Update on March 16 · Persbericht

1 maart 2021 · Motus GI to Participate in Two Upcoming Investor Conferences in March 2021 · Persbericht

27 januari 2021 · Motus GI Announces Warrant Exercise Agreement Resulting in Expected Gross Proceeds to the Company of up to $11 Million · Persbericht

15 januari 2021 · Motus GI Announces European Clearance of Enhanced Pure-Vu® GEN2 System to Harmonize with U.S. Configuration · Persbericht

11 januari 2021 · Motus GI Expands Intellectual Property Portfolio with U.S. Patent for the Pure-Vu® System’s Universal Method to Mount on the End of Most Commercial Colonoscopes · Persbericht

Mijn selecties

Je selectie is nog leeg.

Voeg nu effecten toe